Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition

Carcinogenesis. 2013 May;34(5):1096-104. doi: 10.1093/carcin/bgt012. Epub 2013 Jan 24.

Abstract

Betel quid (BQ) chewing is an oral habit that increases the risk of oral cancer and oral submucous fibrosis (OSF), a precancerous condition showing epithelial atrophy and tissue fibrosis. Persistent fibroblast contraction may induce the fibrotic contracture of tissue. In this study, we found that areca nut extract (ANE) (200-1200 µg/ml) stimulated buccal mucosa fibroblast (OMF)-populated collagen gel contraction. Arecoline but not arecaidine-two areca alkaloids, slightly induced the OMF contraction. Exogenous addition of carboxylesterase (2U/ml) prevented the arecoline- but not ANE-induced OMF contraction. OMF expressed inositol triphosphate (IP3) receptors. ANE-induced OMF (800 µg/ml) contraction was inhibited by U73122 [phospholipase C (PLC) inhibitor] and 2-aminoethoxydiphenyl borate (IP3 receptor antagonist), respectively. Ethylene glycol tetraacetic acid and verapamil, two calcium mobilization modulators, also suppressed the ANE-induced OMF contraction. ANE induced calcium/calmodulin kinase II and myosin light chain (MLC) phosphorylation in OMF. Moreover, W7 (a Ca(2+)/calmodulin inhibitor), HA1077 (Rho kinase inhibitor), ML-7 (MLC kinase inhibitor) and cytochalasin B (actin filament polymerization inhibitor) inhibited the ANE-induced OMF contraction. Although ANE elevated reactive oxygen species (ROS) level in OMF, catalase, superoxide dismutase and N-acetyl-L-cysteine showed no obvious effect on ANE-elicited OMF contraction. These results indicate that BQ chewing may affect the wound healing and fibrotic processes in OSF via inducing OMF contraction by ANE and areca alkaloids. AN components-induced OMF contraction was related to PLC/IP3/Ca(2+)/calmodulin and Rho signaling pathway as well as actin filament polymerization, but not solely due to ROS production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Areca / adverse effects*
  • Arecoline / adverse effects
  • Arecoline / analogs & derivatives
  • Calcium / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / genetics
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Cells, Cultured
  • Fibroblasts / metabolism
  • Fibroblasts / pathology*
  • Humans
  • Inositol 1,4,5-Trisphosphate Receptors / genetics
  • Inositol 1,4,5-Trisphosphate Receptors / metabolism
  • Mouth Mucosa / metabolism
  • Mouth Mucosa / pathology*
  • Mouth Neoplasms / etiology
  • Mouth Neoplasms / genetics
  • Mouth Neoplasms / metabolism
  • Mouth Neoplasms / pathology
  • Myosin Light Chains / genetics
  • Myosin Light Chains / metabolism
  • Nuts / adverse effects*
  • Oral Submucous Fibrosis / chemically induced
  • Oral Submucous Fibrosis / genetics
  • Oral Submucous Fibrosis / metabolism
  • Oral Submucous Fibrosis / pathology*
  • Phosphorylation / genetics
  • Plant Extracts / adverse effects
  • Precancerous Conditions / etiology*
  • Precancerous Conditions / genetics
  • Precancerous Conditions / metabolism
  • Precancerous Conditions / pathology*
  • Reactive Oxygen Species / metabolism
  • Signal Transduction

Substances

  • Inositol 1,4,5-Trisphosphate Receptors
  • Myosin Light Chains
  • Plant Extracts
  • Reactive Oxygen Species
  • arecaidine
  • Arecoline
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium